A VAMS‐based LC–MS/MS method for precise cenobamate quantification in epilepsy (patients)
Abstract Objective Cenobamate (CNB), a recently approved antiseizure medication by the European Medicines Agency (EMA), serves as an adjunctive therapy for focal‐onset seizures in adult patients unresponsive to at least two other treatments. Administered in polytherapy, CNB can potentially interact...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley
2024-12-01
|
| Collection: | Epilepsia Open |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1002/epi4.12927 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|